Tim and Chris discuss an ongoing case, VANDA PHARMACEUTICALS v. United States, which highlights the potential trade secret misappropriation by an FDA official!! This is preceded by a quick discussion of the FTC decision to ban non-compete agreements. More on that topic next week!
Episode 8: Appian’s $2b Trade Secret Win Goes “Poof”
In this episode, Tim and Chris discuss the reversal and remand of the Appian Pegasystems case, which involved a $2 billion damages award. The original case gained attention for its massive damage award and the systematic theft of trade secrets by Pegasystems. The reversal and remand were based on issues of evidence and causation, with the damages calculation not accurately connecting to the trade secrets. The case is still ongoing, with an appeal of the appeal and the possibility of a new trial. The episode also mentions the use of insurance policies to protect against damages and the potential for refiling the case under the DTSA.